Healthcare

CytoDyn’s (OTC: CYDY) Leronlimab (PRO 140) reduces by more than 98% human breast cancer metastasis in mouse xenografts for over 6 weeks

Based on strong results in its pre-clinical animal study, CytoDyn files for Orphan Drug Designation for Triple-Negative Breast Cancer VANCOUVER, Washington, Feb 20, 2019 – CytoDyn Inc. (otc.qb:CYDY), a biotechnology company developing a novel humanized […]

No Picture
Business News

Bombardier to deliver a handful of Global 7500 jets in first half of 2019

Canadian train-and-plane maker Bombardier will deliver a handful of its new flagship Global 7500 business jet to customers during the first half of 2019, with the remaining 10-15 deliveries expected during the back half of the year, chief financial officer John Di Bert told an investor conference on Wednesday.

…read more […]